User profiles for "author:Seung Ki Kim"
Seung-Ki Kim서울대 의과대학 신경외과학 교수 Verified email at snu.ac.kr Cited by 16202 |
Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review
K Pandey, HJ An, SK Kim, SA Lee… - … journal of cancer, 2019 - Wiley Online Library
Deregulation of the cyclin D‐CDK4/6‐INK4‐RB pathway leading to uncontrolled cell
proliferation, is frequently observed in breast cancer. Currently, three selective CDK4/6 …
proliferation, is frequently observed in breast cancer. Currently, three selective CDK4/6 …
Headache in pediatric moyamoya disease: review of 204 consecutive cases
Object Patients with moyamoya disease complain of headache before surgery, after surgery,
or in both periods. To clarify the pathophysiological features of these headaches which are …
or in both periods. To clarify the pathophysiological features of these headaches which are …
[HTML][HTML] The pathophysiology of moyamoya disease: an update
Moyamoya disease (MMD) is a unique cerebrovascular disease characterized by the
progressive stenosis of large intracranial arteries and a hazy network of basal collaterals …
progressive stenosis of large intracranial arteries and a hazy network of basal collaterals …
[PDF][PDF] Intertumoral heterogeneity within medulloblastoma subgroups
While molecular subgrouping has revolutionized medulloblastoma classification, the extent
of heterogeneity within subgroups is unknown. Similarity network fusion (SNF) applied to …
of heterogeneity within subgroups is unknown. Similarity network fusion (SNF) applied to …
[HTML][HTML] Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Medulloblastoma, the most common malignant paediatric brain tumour, is currently treated
with nonspecific cytotoxic therapies including surgery, whole-brain radiation, and aggressive …
with nonspecific cytotoxic therapies including surgery, whole-brain radiation, and aggressive …
Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma
N Zhukova, V Ramaswamy, M Remke… - Journal of Clinical …, 2013 - ascopubs.org
Purpose Reports detailing the prognostic impact of TP53 mutations in medulloblastoma offer
conflicting conclusions. We resolve this issue through the inclusion of molecular subgroup …
conflicting conclusions. We resolve this issue through the inclusion of molecular subgroup …
Pediatric moyamoya disease: an analysis of 410 consecutive cases
Objective Moyamoya disease (MMD) is a cerebrovascular occlusive disease of the bilateral
internal carotid arteries that causes a compensatory abnormal vascular network at the base …
internal carotid arteries that causes a compensatory abnormal vascular network at the base …
Cytogenetic prognostication within medulloblastoma subgroups
Purpose Medulloblastoma comprises four distinct molecular subgroups: WNT, SHH, Group
3, and Group 4. Current medulloblastoma protocols stratify patients based on clinical …
3, and Group 4. Current medulloblastoma protocols stratify patients based on clinical …
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
Background Patients with incomplete surgical resection of medulloblastoma are
controversially regarded as having a marker of high-risk disease, which leads to patients …
controversially regarded as having a marker of high-risk disease, which leads to patients …
Divergent clonal selection dominates medulloblastoma at recurrence
AS Morrissy, L Garzia, DJH Shih, S Zuyderduyn… - Nature, 2016 - nature.com
The development of targeted anti-cancer therapies through the study of cancer genomes is
intended to increase survival rates and decrease treatment-related toxicity. We treated a …
intended to increase survival rates and decrease treatment-related toxicity. We treated a …